BioPharma Credit 

$0.98
98
+$0.04+4.38% Tuesday 18:50

Statistics

Day High
0.83
Day Low
0.83
52W High
1
52W Low
0.78
Volume
36,832
Avg. Volume
787,383
Mkt Cap
0
P/E Ratio
13.38
Dividend Yield
7.18%
Dividend
0.07

Upcoming

Dividends

7.18%Dividend Yield
Mar 26
$0.02
Mar 26
$0.01
Oct 25
$0.02
Oct 25
$0.02
Jul 25
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

25SepExpected
Q4 2021
Q2 2022
Q4 2022
Q2 2023
Q4 2023
Q1 2024
Q2 2024
0.03
0.04
0.04
0.05
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BOPCF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BridgeBio Pharma
BBIO
Mkt Cap12.07B
BridgeBio Pharma focuses on genetic diseases and competes in the biopharma financing space by attracting investments for its projects.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company with a significant investment arm for biopharma ventures, competing for similar investment opportunities.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences invests in biopharma companies and projects, directly competing with BioPharma Credit's investment model.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb, through its venture arm, competes in the biopharma credit and investment space.
Merck
MRK
Mkt Cap214.76B
Merck & Co., with its venture capital initiatives, competes for similar biopharma investments and financing opportunities.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its J&J Innovation and JLABS units, competes in the biopharma investment and financing space.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, with its venture investment arm, competes for opportunities in biopharma credit and financing.
AMGEN
AMGN
Mkt Cap160.66B
Amgen, through its venture investments, competes in the biopharma financing space, targeting similar companies and projects.
Novartis
NVS
Mkt Cap237.61B
Novartis, with its significant investments in biopharma companies, competes directly with BioPharma Credit's financing model.
Sanofi
SNY
Mkt Cap124.45B
Sanofi, through its venture capital arm, competes in the biopharma credit market, financing similar types of companies and projects.

About

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom.
Show more...
CEO
Mr. Pedro Gonzalez de Cosio
Country
GB
ISIN
GB00BDGKMY29

Listings

0 Comments

Share your thoughts

FAQ

What is BioPharma Credit stock price today?
The current price of BOPCF is $0.98 USD — it has increased by +4.38% in the past 24 hours. Watch BioPharma Credit stock price performance more closely on the chart.
What is BioPharma Credit stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioPharma Credit stocks are traded under the ticker BOPCF.
What were BioPharma Credit earnings last quarter?
BOPCF earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does BioPharma Credit pay dividends?
Yes, BOPCF dividends are paid quarterly. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 7.18%.
When did BioPharma Credit complete a stock split?
BioPharma Credit has not had any recent stock splits.
Where is BioPharma Credit headquartered?
BioPharma Credit is headquartered in London, GB.